Generate:Biomedicines
A Technical Program Manager or Senior Technical Program Manager at Generate Biomedicines coordinates interdisciplinary scientific programs integrating machine learning, computational biology, and experimental biology to produce novel therapeutics. They drive cross-functional research and engineering roadmaps, enable platform capabilities across wet and dry lab teams, and ensure efficient collaboration across disciplines.
Headquarters
Somerville, Massachusetts, United States
Company Size
201-500 employees
Generate:Biomedicines is a therapeutics company that combines machine learning, computational biology, and biological engineering to design and develop precision protein medicines and antibodies. Using generative AI and lab-driven engineering, the company builds targeted biologics and epitope-focused candidates, advancing a pipeline from discovery through clinical development. Its clinical-stage programs include GB-0895, a long‑acting anti‑TSLP antibody progressing to global Phase 3 studies, and the company has recently completed an initial public offering. Generate was incubated by Flagship Pioneering and emphasizes platform-driven discovery to accelerate novel biologic therapeutics.
AI Meets Biotech The High Stakes IPO of Generate Biomedicines – The Stillman Exchange
4 days ago
Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering
2 weeks ago
Generate Biomedicines Shares Plummet After $400 Million Market Debut
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Generate:Biomedicines.
12% above the average for this role
Generate caps a strong month for biotech IPOs with $400M offering
2 weeks ago
Senior Scientist in Computational Biology
Eikon Therapeutics
Executive Director, Computational Biology
Insmed Incorporated
Associate Director Computational Biology, Cardio-Renal-Metabolic diseases
Digital Biology
Scientist/Senior Scientist, Computational Biology
Volastra Therapeutics
Intern, Discovery Data Science (Project: Predicting splice-mediated therapeutic escape of antibody targets in cancer)
Genmab
Senior Scientist – Protein Design
AstraZeneca